×
Newsmax TV & Webwww.newsmax.comFREE - In Google Play
VIEW
×
Newsmax TV & Webwww.newsmax.comFREE - On the App Store
VIEW
Skip to main content
Tags: Virus Outbreak | Biden

Fauci: US to Spend $3.2B for COVID-19 Antiviral Pills

Fauci: US to Spend $3.2B for COVID-19 Antiviral Pills

Thursday, 17 June 2021 11:59 AM EDT

The United States is devoting $3.2 billion to advance development of antiviral pills for COVID-19 and other dangerous viruses that could turn into pandemics.

Dr. Anthony Fauci, the nation’s top infectious disease expert, announced the investment during a White House briefing as part of a new “antiviral program for pandemics” to develop drugs to address symptoms caused by potentially dangerous viruses like the coronavirus.

The pills for COVID-19, which would be used to minimize symptoms after infection, are in development and could begin arriving by year’s end, pending the completion of clinical trials. The funding will speed those clinical trials and provide additional support private sector research, development and manufacturing.

Fauci said the new program would invest in “accelerating things that are already in progress” for COVID-19, but also work to innovate new therapies for other viruses.

“There are few treatments that exist for many of the viruses that have pandemic potential," said Fauci.

But he added, “vaccines clearly remain the centerpiece of our arsenal.”

News of the administration's plans for the pill was first reported Thursday by The New York Times.

© Copyright 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.


Newsfront
The United States is devoting $3.2 billion to advance development of antiviral pills for COVID-19 and other dangerous viruses that could turn into pandemics.Dr. Anthony Fauci, the nation's top infectious disease expert, announced the investment during a White House briefing...
Virus Outbreak, Biden
182
2021-59-17
Thursday, 17 June 2021 11:59 AM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
TOP

Interest-Based Advertising | Do not sell or share my personal information

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved
Download the NewsmaxTV App
Get the NewsmaxTV App for iOS Get the NewsmaxTV App for Android Scan QR code to get the NewsmaxTV App
NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved